EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,516,730 | -22.1% | 788,260 | +5.3% | 0.00% | – |
Q2 2023 | $5,799,883 | +32.0% | 748,372 | +13.6% | 0.00% | – |
Q1 2023 | $4,393,015 | -59.0% | 658,623 | -45.1% | 0.00% | – |
Q4 2022 | $10,719,418 | +93.7% | 1,199,040 | +113.2% | 0.00% | – |
Q3 2022 | $5,533,000 | +32.5% | 562,326 | +7.2% | 0.00% | – |
Q2 2022 | $4,177,000 | -23.7% | 524,724 | -7.0% | 0.00% | – |
Q1 2022 | $5,473,000 | -32.2% | 564,210 | +6.7% | 0.00% | – |
Q4 2021 | $8,078,000 | +144.4% | 528,638 | +165.5% | 0.00% | – |
Q3 2021 | $3,305,000 | -12.7% | 199,096 | +12.2% | 0.00% | – |
Q2 2021 | $3,786,000 | – | 177,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |